Cost-effectiveness of highly active antiretroviral therapy in South Africa

Journal Article

2005

Permanent link to this Item
http://hdl.handle.net/11427/15283
 http://dx.doi.org/10.1371/journal.pmed.0030004
Files
Badri_Cost_Effectiveness_of_HAART_2005.pdf (130.39 KB)
Authors
Badri, Motasim
Maartens, Gary
Mandalia, Sundhiya
Bekker, Linda-Gail
Penrod, John R
Platt, Robert W
Wood, Robin
Beck, Eduard J
Journal Title

PLOS Medicince

Link to Journal
http://journals.plos.org/plosmedicine
Journal ISSN
Volume Title
Publisher

Public Library of Science

Publisher

University of Cape Town

Department
Desmond Tutu HIV Centre
Faculty
Faculty of Health Sciences
License

http://creativecommons.org/licenses/by/4.0

Series
Abstract
Healthcare costs for HIV-infected South African adults on HAART compared with costs for HIV-infected controls not on HAART. Authors conclude HAART is cost effective.
Description
Keywords
Highly-active antiretroviral therapy
AIDS
Inpatients
Outpatients
HIV
Antiretroviral therapy
Cost-effectiveness analysis
HIV infections

Reference:

Badri, M., Maartens, G., Mandalia, S., Bekker, L., Penrod, J. R., Platt, R. W., ... & Beck, E. J. (2006). Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Medicine, 3(1), 48. doi:10.1371/journal.pmed.0030004

Collections
Journal Articles